Literature DB >> 27363401

Visit-to-visit variation of fasting plasma glucose is a predictor of hip fracture in older persons with type 2 diabetes: the Taiwan Diabetes Study.

J I-H Chiang1, T-C Li2,3, C-I Li4,5, C-S Liu4,5,6, N-H Meng4,7, W-Y Lin4,6, S-Y Yang2, H-J Chen8, C-C Lin9,10,11.   

Abstract

We investigated the association between fasting plasma glucose variability (FPG-CV) and the risk of hip fracture in elderly diabetic patients. Our finding showed a temporal association between FPG-CV and hip fracture as patients categorized as FPG-CV greater than 25.4 % showed an increased risk in hip fractures.
INTRODUCTION: Hip fracture is a major health burden in the population and is associated with high rates of mortality and morbidity especially in elderly. It is evident that diabetes mellitus is a risk factor of osteoporosis which is a significant risk factor of hip fracture. However, epidemiological studies exploring the risks of hip fracture among type 2 diabetic patients are limited.
METHODS: A retrospective study of 26,501 ethnic Chinese older persons enrolled in the National Diabetes Care Management program in Taiwan was conducted; related factors were analyzed with extended Cox proportional hazards regression models to competing risk data on hip fracture incidence.
RESULTS: The results show a temporal association between FPG-CV and hip fracture as patients categorized as FPG-CV greater than 25.4 % showed an increased risk in hip fractures, confirming a linear relationship between the two. After multivariate adjustment, the risk of hip fracture increased among patients with FPG-CV of 25.4-42.3 % and >42.3 % compared with patients with FPG-CV of ≦ 14.3 % (hazard ratio, 1.35; 95 % confidence interval 1.14-1.60 and 1.27; 1.07-1.52, respectively). Significant linear trends among various FPG-CV were observed.
CONCLUSIONS: Thus, the present study demonstrated the importance of glucose stability for fracture prevention in older persons with type 2 diabetes. Future studies should be conducted to explore whether reduction in glucose oscillation in older adults with diabetes mellitus can reduce the risk of hip fracture.

Entities:  

Keywords:  Fasting plasma glucose variability; Hip fracture; Type 2 diabetes

Mesh:

Substances:

Year:  2016        PMID: 27363401     DOI: 10.1007/s00198-016-3689-1

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  44 in total

1.  Influence of nonenzymatic glycation on biomechanical properties of cortical bone.

Authors:  D Vashishth; G J Gibson; J I Khoury; M B Schaffler; J Kimura; D P Fyhrie
Journal:  Bone       Date:  2001-02       Impact factor: 4.398

2.  Oxidative stress modulates osteoblastic differentiation of vascular and bone cells.

Authors:  N Mody; F Parhami; T A Sarafian; L L Demer
Journal:  Free Radic Biol Med       Date:  2001-08-15       Impact factor: 7.376

Review 3.  Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications.

Authors:  P Lips
Journal:  Endocr Rev       Date:  2001-08       Impact factor: 19.871

4.  Bone structure and turnover in type 2 diabetes mellitus.

Authors:  A Shu; M T Yin; E Stein; S Cremers; E Dworakowski; R Ives; M R Rubin
Journal:  Osteoporos Int       Date:  2011-03-19       Impact factor: 4.507

5.  Glycated Hemoglobin Level and Risk of Hip Fracture in Older People with Type 2 Diabetes: A Competing Risk Analysis of Taiwan Diabetes Cohort Study.

Authors:  Chia-Ing Li; Chiu-Shong Liu; Wen-Yuan Lin; Nai-Hsin Meng; Ching-Chu Chen; Sing-Yu Yang; Hsuan-Ju Chen; Cheng-Chieh Lin; Tsai-Chung Li
Journal:  J Bone Miner Res       Date:  2015-07       Impact factor: 6.741

Review 6.  Glycation of collagen: the basis of its central role in the late complications of ageing and diabetes.

Authors:  R G Paul; A J Bailey
Journal:  Int J Biochem Cell Biol       Date:  1996-12       Impact factor: 5.085

7.  Glucose-induced inhibition of in vitro bone mineralization.

Authors:  E Balint; P Szabo; C F Marshall; S M Sprague
Journal:  Bone       Date:  2001-01       Impact factor: 4.398

8.  Intermittent high glucose enhances apoptosis related to oxidative stress in human umbilical vein endothelial cells: the role of protein kinase C and NAD(P)H-oxidase activation.

Authors:  Lisa Quagliaro; Ludovica Piconi; Roberta Assaloni; Lucia Martinelli; Enrico Motz; Antonio Ceriello
Journal:  Diabetes       Date:  2003-11       Impact factor: 9.461

9.  The components of excess mortality after hip fracture.

Authors:  J A Kanis; A Oden; O Johnell; C De Laet; B Jonsson; A K Oglesby
Journal:  Bone       Date:  2003-05       Impact factor: 4.398

10.  A1C variability and the risk of microvascular complications in type 1 diabetes: data from the Diabetes Control and Complications Trial.

Authors:  Eric S Kilpatrick; Alan S Rigby; Stephen L Atkin
Journal:  Diabetes Care       Date:  2008-07-23       Impact factor: 17.152

View more
  4 in total

1.  Association of glycaemic variability evaluated by continuous glucose monitoring with diabetic peripheral neuropathy in type 2 diabetic patients.

Authors:  Yu-Ming Hu; Li-Hua Zhao; Xiu-Lin Zhang; Hong-Li Cai; Hai-Yan Huang; Feng Xu; Tong Chen; Xue-Qin Wang; Ai-Song Guo; Jian-An Li; Jian-Bin Su
Journal:  Endocrine       Date:  2018-02-06       Impact factor: 3.633

2.  HbA1c variability and diabetic peripheral neuropathy in type 2 diabetic patients.

Authors:  Jian-Bin Su; Li-Hua Zhao; Xiu-Lin Zhang; Hong-Li Cai; Hai-Yan Huang; Feng Xu; Tong Chen; Xue-Qin Wang
Journal:  Cardiovasc Diabetol       Date:  2018-03-29       Impact factor: 9.951

3.  Efficacy of bisphosphonate therapy on postmenopausal osteoporotic women with and without diabetes: a prospective trial.

Authors:  Jinyoung Kim; Kyoung Min Kim; Soo Lim; Moo-Il Kang; Ki-Hyun Baek; Yong-Ki Min
Journal:  BMC Endocr Disord       Date:  2022-04-11       Impact factor: 2.763

4.  Longitudinal changes in fasting plasma glucose are associated with risk of cancer mortality: A Chinese cohort study.

Authors:  Mengyin Wu; Jieming Lu; Zongming Yang; Peng Shen; Zhebin Yu; Mengling Tang; Mingjuan Jin; Hongbo Lin; Kun Chen; Jianbing Wang
Journal:  Cancer Med       Date:  2021-06-21       Impact factor: 4.452

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.